Abstract
The lipid metabolism of 93 patients with renal transplantation was prospectively studied. It was characterized by the serum levels of cholesterol, HDL, LDL, triglyceride, apolipoprotein A1, Apo B and lipoprotein (a) as well as by lipid electrophoresis. In addition to the examination of lipid concentrations, the authors looked for correlations with other metabolic changes, immunosuppressive treatment and the changes of body weight and hypertension following transplantation. Their conclusion is that hyperlipidaemic and dyslipidaemic changes, as reflected by the levels of total cholesterol, LDL and Apo B, are more considerable in women than in men. The levels of pre-beta and beta lipoprotein were not significantly lower in men than in women. With the passing of time after transplantation and with the reduction of the doses of cyclosporine and corticosteroids, the values of hypertension, hyper-lipidaemia and dyslipidaemia decreased. According to the follow-up results, the lipid values measured in the winter and autumn months are higher than those found in the summer. The importance of early and follow-up examinations and of the reduction of pathological metabolic alterations is emphasized.
Similar content being viewed by others
References
Bagdade, J., Casaretta, A., Alberts, J.: Effects of chronic uraemia, hemodialysis and renal transplantation on plasma lipids and lipoproteins in man.J. Lab. Clin. Med., 87, 37 (1976).
Barbagello, C. M., Averna, M. R., Sparacino, V., Galione, F., Scafidi, V., Amato, S., Mancino, C., Cefalu, A. B., Notarbartolo, A.: Lipoprotein (a) levels in end-stage renal failure and transplantation.Nephron, 64, 560 (1993).
Brown, J. H., Anwar, N., Short, C. D., Bhatnager, D., Mackness, M. I., Hunt, L. P., Durrington, P. N.: Serum lipoprotein (a) in renal transplant recipients receiving cyclosporin monotherapy.Nephrol. Dial. Transplant., 8, 863 (1993).
Blünke, M., Keller, E., Eble, F., Nausner, M., Kirste, G.: Obesity in kidney transplant patients as a risk factor.Transplant. Proc., 25, 2618 (1993).
Cressman, M. D., Abood, D. O., Neil, J., Hoff, H. F.: Lp (a) and premature mortality during chronic hemodialysis treatment.Chem. Phys. Lipids, 67/68, 419 (1994).
Dimeny, E., Tufveson, G., Lithell, H., Larsson, E., Siegbahn, A., Fellstrom, B.: The influence of retransplant lipoprotein abnormalities on the early results of renal transplantation.Eur. J. Clin. Invest., 23, 572 (1993).
Domán, J., Pálos, G.: Hyperlipidaemia as a risk factor in the progression of renal diseases (in Hungarian).Magy. Belorv. Arch., 46, 343 (1993).
Esterbauer, H., Wag, G., Puhl, H.: Lipid peroxidation and its role in atherosclerosis.Br. Med. Bull., 49, 566 (1993).
Fellstrom, B. C., Larsson, E.: Pathogenesis and treatment perspectives of chronic graft rejection (CVR).Immunol. Rev., 134, 83 (1993).
Femaris, J. R., Pasqualini, T.: Therapy with a new glucocortocoid: Effect of deflazacort on linear growth and growth hormone secretion in renal transplantation.J. Rheumatol., Suppl.,37, 43 (1993).
Galle, J., Schollmeyer, P., Wanner, C.: Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: Influence of the endothelium.Eur. Heart J., 14 (Suppl. 1) 111 (1993).
Gill, I. S., Hodge, E. E., Novick, A. C., Steinmuller, D. R., Garred, D.: Impact of obesity on renal transplantation.Transplant. Proc., 25, 1047 (1993).
Hricik, D. E., Kupin, W. L., First, M. R.: Steroid free immunosuppression after renal transplantation.J. Am. Soc. Nephrol., 4 (Suppl. 8) S 10 (1994).
Isoniemi, H. M., Ahonen, J., Tikkanen, M. J., von Willebrand, E. O., Krogerus, L., Eklund, B. H., Hockerstedt, K. V., Samela, K. E., Hayry, P. J.: Long-term consequences of different immunosuppressive regimens for renal allografts.Transplantation, 55, 494 (1993).
Isoniemi, H., Nurminen, M., Tikkanen, M. J., von Willebrand, E., Krogerus, L., Ahonen, J., Eklund, B., Hockerstedt, K., Salmela, K., Hayry, P.: Risk factors predicting chronic rejection of renal allografts.Transplantation, 57, 68 (1994).
Johnson, C. P., Gallagher, L. S., Zhu, Y. R., Porth, C., Kelber, S., Roza, A. M., Adams, M. B.: Factors influencing weight gain after renal transplantation.Transplantation, 56, 822 (1993).
Kasiske, B. L., Umen, A. J.: Persistent hyperlipidemia in renal transplant patients.Medicine, 66, 309 (1987).
Keane, W. F.: Lipids and the kidney.Kidney Int., 46, 910 (1994).
Kuster, G. M., Drexel, H., Bleisch, J. A., Rentsch, K., Pei, P., Binswanger, U., Amann, F. W.: Relation of cyclosporine blood levels to adverse effects on lipoproteins.Transplantation, 57, 1479 (1994).
Mathieu, R. L., Casez, J. P., Jaeger, P., Montandon, A., Peheim, E., Horber, F. F.: Altered body composition and fuel metabolism in stable kidney transplant patients on immunosuppressive monotherapy with cyclosporin-A.Eur. J. Clin. Invest., 24, 195 (1994).
Maggi, E., Belazzi, R., Falaschi, F., Frattoni, A., Perani, G., Finardi, G., Gazo, A., Nai, M., Romanini, D., Bellomo, G.: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?Kidney Int., 45, 876 (1994).
Manske, C. L., Kasiske, B. L.: Lipid abnormalities after renal transplantation. In: Keane, W. F., Stein, J. H. (eds): Contemporary Issues in Nephrology. Vol. 24. Churchill Livingstone, New York 1991, pp. 37–62.
Moore, R., Thomas, D., Morgan, E., Wheeler, D., Griffin, P., Salaman, J., Rees, A.: Abnormal lipid and lipoprotein profiles following renal transplantation.Transplant. Proc., 25, 1060 (1993).
Pincemail, J., Defraigne, J. O., Franssen, C., Bonnet, P., Deby-Dupont, G., Pirenne, J., Deby, C., Lamy, M., Limet, M., Meurisse, M.: Evidence for free radical formation during human kidney transplantation.Free Radic. Biol. Med., 15, 343 (1993).
Rabl, H., Khoschsorur, G., Colombo, T., Petritsch, P., Rauchenwald, M., Koltringer, P., Tatzber, F., Esterbauer, H.: A multivitamin infusion prevents lipid peroxidation and improves transplantation performance.Kidney Int., 43, 912 (1993).
Schulak, J. A., Hricik, D. E.: Steroid withdrawal, after transplantation.Clin. Transplant., 8, 211 (1994).
Traindl, O., Reading, S., Franz, M., Watschinger, B., Klauser, R., Pidlich, H., Wildhalm, K., Pohanka, E., Kovarik, J.: Treatment of hyperlipidemic kidney graft recipients with Lovastatin: Effect on LDL-cholesterol and lipoprotein (a).Nephron, 62, 394 (1992).
Webb, A. T., Reaveley, D. A., O'Donnell, B., Seed, M., Brown, E. A.: Does cyclosporin increase lipoprotein (a) concentrations in renal transplant recipients?Lancet, 341, 268 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lőcsey, L., Asztalos, L., Kincses, Z. et al. Dyslipidaemia and hyperlipidaemia following renal transplantation. International Urology and Nephrology 28, 419–430 (1996). https://doi.org/10.1007/BF02550506
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550506